[Ip-health] MPP and Unitaid Symposium at the 22nd International AIDS Conference - Tuesday 24 July, 18:30-20:30

Sophie Thievenaz sthievenaz at medicinespatentpool.org
Fri Jul 20 06:00:09 PDT 2018


The Medicines Patent Pool (MPP) and Unitaid are honoured to invite you to a Satellite Symposium during the 22nd International AIDS Conference.

Meet the manufacturers of HIV and HCV treatments: challenges and opportunities for treatment scale-up

Manufacturers, licensees of the MPP, will discuss the new adult and paediatric formulations they are currently developing or have recently introduced; roll-out plans and timelines; existing challenges and opportunities; and market trends. An interactive Q&A session will follow.

Tuesday 24 July 2018, from 18:30 to 20:30

Emerald room
RAI Amsterdam Convention Centre
Europaplein 24
1078 GZ Amsterdam
Netherlands

All conference participants are welcome to join.

Light refreshments will be served 30 minutes before the event.

To register: https://www.eventbrite.co.uk/e/meet-the-manufacturers-of-hiv-and-hcv-treatments-challenges-and-opportunities-for-treatment-scale-up-registration-47220607107?aff=escb&utm-source=cp&utm-term=listing&utm-campaign=social&utm-medium=discovery&utm-content=attendeeshare

Download the Invitation:
https://medicinespatentpool.org/uploads/2018/07/Invitation_Satellite_AIDS2018_FINAL.pdf

Download full MPP programme @ AIDS 2018:
https://medicinespatentpool.org/uploads/2018/07/MPP-programme_IAS2018_digital_emailing_2.pdf

Agenda:

18:30-19:00

Opening remarks by co-chairs
Charles Gore, Executive Director, Medicines Patent Pool (MPP) and Alexandra Volgina, Program Manager, GNP+

Introductory presentations

“From pipelines to frontlines and the role of manufacturers: challenges and opportunities in facilitating the introduction of new HIV and HCV treatments in low- and middle-income countries” – Robert Matiru, Director of Operations, Unitaid
“Accelerating access to new WHO recommended generic medicines and formulations” – Esteban Burrone, Head of Policy, MPP and Aastha Gupta, Head of Business Development a.i., MPP
“Transition to new treatments and formulations” – Françoise Renaud, Department of HIV/AIDS, World Health Organization

19:00-20:30

Panel discussion moderated by co-chairs

Arvind Kanda, Senior Vice President – Head HIV and Infectious Diseases, API, South Africa and Sub-Saharan Africa, Mylan
Balaji UD, Senior Director, Global HIV/AIDS Initiatives, Emcure Pharmaceuticals
Chandrakanth Chereddi, Executive Director & Head – Generics FDF Division, Laurus Labs
Jos Perriëns, Strategic Advisor Access Markets, Hetero Corporate
Shailesh Pednekar, Senior Vice President – International Business, Macleods
Umesh K, Vice President and Business Unit Head, Global Anti-Virals, Aurobindo Pharma

Q&A session
Closing remarks

Sophie Thievenaz | Communications Manager | Medicines Patent Pool
Tel: +41 22 533 5063 | Mob: +41 79 870 85 52
E-mail: sthievenaz at medicinespatentpool.org<mailto:sthievenaz at medicinespatentpool.org>


More information about the Ip-health mailing list